These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32083512)

  • 1. Mutational Variation Analysis of
    Suresh M; Skariyachan S; Narayanan N; Pullampara Rajamma J; Panickassery Ramakrishnan MK
    Microb Drug Resist; 2020 Aug; 26(8):869-879. PubMed ID: 32083512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
    Lee JY; Ko KS
    Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
    El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
    APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the oprD porin gene by a novel insertion sequence ISPa195 associated with large deletion in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
    Bocharova Y; Savinova T; Shagin DA; Shelenkov AA; Mayanskiy NA; Chebotar IV
    J Glob Antimicrob Resist; 2019 Jun; 17():309-311. PubMed ID: 30684654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Location of OprD porin in Pseudomonas aeruginosa clinical isolates.
    González-Vázquez MC; Rocha-Gracia RDC; Carabarín-Lima A; Bello-López E; Huerta-Romano F; Martínez-Laguna Y; Lozano-Zarain P
    APMIS; 2021 Apr; 129(4):213-224. PubMed ID: 33471435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipenem resistance associated with amino acid alterations of the OprD porin in Pseudomonas aeruginosa clinical isolates.
    Nazari M; Ahmadi H; Hosseinzadeh S; Sahebkar A; Khademi F
    Acta Microbiol Immunol Hung; 2023 Sep; 70(3):206-212. PubMed ID: 37342895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
    Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
    Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O
    Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis for the OprD gene among Pseudomonas aueroginosa clinical isolates obtained from hospitals in Jordan.
    Abu Khadra KM; Al-Rabaia SY; Khalil AM; Abu-Qatouseh LF; Abussaud MJ
    J Infect Dev Ctries; 2022 Apr; 16(4):683-690. PubMed ID: 35544631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
    Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC
    J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids.
    Ochs MM; McCusker MP; Bains M; Hancock RE
    Antimicrob Agents Chemother; 1999 May; 43(5):1085-90. PubMed ID: 10223918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenem resistance in cystic fibrosis strains of Pseudomonas aeruginosa as a result of amino acid substitutions in porin OprD.
    Richardot C; Plésiat P; Fournier D; Monlezun L; Broutin I; Llanes C
    Int J Antimicrob Agents; 2015 May; 45(5):529-32. PubMed ID: 25735764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and antibiotic resistance of Pseudomonas aeruginosa in water samples in central Italy and molecular characterization of oprD in imipenem resistant isolates.
    Schiavano GF; Carloni E; Andreoni F; Magi S; Chironna M; Brandi G; Amagliani G
    PLoS One; 2017; 12(12):e0189172. PubMed ID: 29211780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer Program for Detection and Analyzing the Porin-Mediated Antibiotic Resistance of Bacteria.
    Savinova TA; Samchenko AA; Bocharova YA; Mayansky NA; Chebotar IV
    Sovrem Tekhnologii Med; 2021; 13(6):15-22. PubMed ID: 35265355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].
    Santella G; Pollini S; Docquier JD; Almuzara M; Gutkind G; Rossolini GM; Radice M
    Rev Panam Salud Publica; 2011 Dec; 30(6):545-8. PubMed ID: 22358400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates.
    Naenna P; Noisumdaeng P; Pongpech P; Tribuddharat C
    Southeast Asian J Trop Med Public Health; 2010 May; 41(3):614-24. PubMed ID: 20578550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and genetic resistance traits of Pseudomonas aeruginosa strains infecting cystic fibrosis patients: A French cohort study.
    Courtois N; Caspar Y; Maurin M
    Int J Antimicrob Agents; 2018 Sep; 52(3):358-364. PubMed ID: 29775685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates.
    Pirnay JP; De Vos D; Mossialos D; Vanderkelen A; Cornelis P; Zizi M
    Environ Microbiol; 2002 Dec; 4(12):872-82. PubMed ID: 12534469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.
    Wolter DJ; Smith-Moland E; Goering RV; Hanson ND; Lister PD
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):43-50. PubMed ID: 15380277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
    Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
    J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.